Anthem Blue Cross Blue Shield of Georgia prior authorization, page 54

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
Q5140Injection, adalimumab-fkjp, biosimilar, 1 mg(cid:9)Standard Local Prior Authorization Code List, Pg 123 Original policy
Q5141Injection, adalimumab-aaty, biosimilar, 1 mg(cid:9)Standard Local Prior Authorization Code List, Pg 123 Original policy
Q5142Injection, adalimumab-ryvk biosimilar, 1 mg(cid:9)Standard Local Prior Authorization Code List, Pg 123 Original policy
Q5143Injection, adalimumab-adbm, biosimilar, 1 mg(cid:9)Standard Local Prior Authorization Code List, Pg 123 Original policy
Q5144Injection, adalimumab-aacf (Idacio), biosimilar, 1 mg(cid:9)Standard Local Prior Authorization Code List, Pg 124 Original policy
Q5145Injection, adalimumab-afzb (Abrilada), biosimilar, 1 mg(cid:9)Standard Local Prior Authorization Code List, Pg 124 Original policy
Q5147Injection, aflibercept-ayyh (Pavblu), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q5149Injection, aflibercept-abzv (Enzeevu), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q5150Injection, aflibercept-mrbb (Ahzantive), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q5151Injection, eculizumab-aagh (Epysqli), biosimilar, 2 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q5152Injection, eculizumab-aeeb (Bkemv), biosimilar, 2 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q5153Injection, aflibercept-yszy (opuviz), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q5154Injection, omalizumab-igec (Omlyclo), biosimilar, 5 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q5155Injection, aflibercept-jbvf (Yesafili), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q5164Injection, ustekinumab-hmny (starjemza), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q5168Injection, ranibizumab-leyk (nufymco), biosimilar, 0.1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q5170Injection, aflibercept-boav (eydenzelt), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q9996Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q9997Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q9998Injection, ustekinumab-aekn (selarsdi), 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
Q9999Injection, ustekinumab-aauz (Otulfi), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 124 Original policy
11920Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.0 sq cm or lessStandard Local Prior Authorization Code List, Pg 124 Original policy
11921Tattooing, intradermal introduction of insoluble opaque pigments to correct color defects of skin, including micropigmentation; 6.1 to 20.0 sq cmStandard Local Prior Authorization Code List, Pg 124 Original policy
11950Subcutaneous injection of filling material (eg, collagen); 1 cc or lessStandard Local Prior Authorization Code List, Pg 124 Original policy
11951Subcutaneous injection of filling material (eg, collagen); 1.1 to 5.0 ccStandard Local Prior Authorization Code List, Pg 124 Original policy
11952Subcutaneous injection of filling material (eg, collagen); 5.1 to 10.0 ccStandard Local Prior Authorization Code List, Pg 124 Original policy
11954Subcutaneous injection of filling material (eg, collagen); over 10.0 ccStandard Local Prior Authorization Code List, Pg 124 Original policy
14040Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10 sq cm or lessStandard Local Prior Authorization Code List, Pg 124 Original policy
14041Adjacent tissue transfer or rearrangement, forehead, cheeks, chin, mouth, neck, axillae, genitalia, hands and/or feet; defect 10.1 sq cm to 30.0 sq cmStandard Local Prior Authorization Code List, Pg 124 Original policy
14060Adjacent tissue transfer or rearrangement, eyelids, nose, ears and/or lips; defect 10 sq cm or lessStandard Local Prior Authorization Code List, Pg 125 Original policy
14061Adjacent tissue transfer or rearrangement, eyelids, nose, ears and/or lips; defect 10.1 sq cm to 30.0 sq cmStandard Local Prior Authorization Code List, Pg 125 Original policy
15150Tissue cultured skin autograft, trunk, arms, legs; first 25 sq cm or lessStandard Local Prior Authorization Code List, Pg 125 Original policy
15155Tissue cultured skin autograft, face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits; first 25 sq cm or lessStandard Local Prior Authorization Code List, Pg 125 Original policy
15271Application of skin substitute graft to trunk, arms, legs, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface areaStandard Local Prior Authorization Code List, Pg 125 Original policy
15273Application of skin substitute graft to trunk, arms, legs, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and childrenStandard Local Prior Authorization Code List, Pg 125 Original policy
15275Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area up to 100 sq cm; first 25 sq cm or less wound surface areaStandard Local Prior Authorization Code List, Pg 125 Original policy
15277Application of skin substitute graft to face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, and/or multiple digits, total wound surface area greater than or equal to 100 sq cm; first 100 sq cm wound surface area, or 1% of body area of infants and childrenStandard Local Prior Authorization Code List, Pg 125 Original policy
15771Grafting of autologous fat harvested by liposuction technique to trunk, breasts, scalp, arms, and/or legs; 50 cc or less injectateStandard Local Prior Authorization Code List, Pg 125 Original policy
15773Grafting of autologous fat harvested by liposuction technique to face, eyelids, mouth, neck, ears, orbits, genitalia, hands, and/or feet; 25 cc or less injectateStandard Local Prior Authorization Code List, Pg 125 Original policy
15775Punch graft for hair transplant; 1 to 15 punch graftsStandard Local Prior Authorization Code List, Pg 125 Original policy
15776Punch graft for hair transplant; more than 15 punch graftsStandard Local Prior Authorization Code List, Pg 125 Original policy
15780Dermabrasion; total face (eg, for acne scarring, fine wrinkling, rhytids, general keratosis)Standard Local Prior Authorization Code List, Pg 125 Original policy
15781Dermabrasion; segmental, faceStandard Local Prior Authorization Code List, Pg 125 Original policy
15782Dermabrasion; regional, other than faceStandard Local Prior Authorization Code List, Pg 125 Original policy
15783Dermabrasion; superficial, any site (eg, tattoo removal)Standard Local Prior Authorization Code List, Pg 125 Original policy
15786Abrasion; single lesion (eg, keratosis, scar)Standard Local Prior Authorization Code List, Pg 126 Original policy
15788Chemical peel, facial; epidermalStandard Local Prior Authorization Code List, Pg 126 Original policy
15789Chemical peel, facial; dermalStandard Local Prior Authorization Code List, Pg 126 Original policy
15792Chemical peel, nonfacial; epidermalStandard Local Prior Authorization Code List, Pg 126 Original policy
15793Chemical peel, nonfacial; dermalStandard Local Prior Authorization Code List, Pg 126 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.